In the second study we evaluated the prognostic value of WAVE3 mRNA expression levels in the circulating tumor cells in the peripheral blood of women with operable breast cancer, based on the unique characteristic of the lack of WAVE3 expression in the peripheral blood mononuclear cells (PBMCs). The gene discussed is WASF3; the disease is breast cancer.